I"”<h4 id="situation">Situation</h4>
<ul>
  <li>The client was a $150M+ division of a multinational pharma company</li>
  <li>The company had recently lagged forecasted performance and profitability targets</li>
  <li>A large customer had dropped their demand significantly (&gt;50%)</li>
  <li>The product portfolio was skewed towards lower-margin products</li>
  <li>The companies operating model and budgets were flexible to react to the current product mix and volume</li>
</ul>

<h4 id="bespoke-solutions">Bespoke Solutions</h4>
<ul>
  <li>SLKone worked with leadership to define objectives and cost targets</li>
  <li>Evaluated sub-ledger cost details to understand true drivers of spend and areas for improvement</li>
  <li>Defined activities, roles, and positions to align business strategy with sustainable organization structures</li>
  <li>Created a site consolidation model to evaluate manufacturing capacity constraints and financial impacts</li>
  <li>Performed commercial analyses evaluating several scenarios of customer and product mix to improve bottom-line financials</li>
  <li>Evaluated manufacturing equipment utilization and warehousing storage to minimize excess overhead costs</li>
</ul>

<h4 id="leading-with-results">Leading With Results</h4>
<ul>
  <li><strong>Identified the need for a ‚ÄúCost Containment Culture‚Äù</strong> by establishing functional targets and specific recommendations to reduce spend</li>
  <li><strong>Improved reporting structure</strong> to align leadership, commercial, and manufacturing functions around metrics and measures</li>
  <li><strong>Developed a proactive product portfolio approach</strong> leveraging scenario-based models including financial and operational impacts to manage commercial strategies</li>
  <li><strong>Identified 50% Increase in EBITDA</strong> through opportunities including: increasing span of control, reducing indirect spend, adjusting manufacturing scheduling to volume, and commercial / customer changes</li>
</ul>
:ET